Lupin 2024

prescription drug abuse

HDA hails drug information-sharing agreement

HDA hails  drug information-sharing agreement

ARLINGTON, Va. — Healthcare Distribution Alliance (HDA) president and CEO John Gray welcomed Attorney General Jeff Sessions’ announcement yesterday of a prescription drug information-sharing agreement between the Drug Enforcement Administration and the attorneys general of 46 states, the District of Columbia and Puerto Rico. Through this agreement, the DEA will share information from its Automation

Community pharmacy shows its resiliency

Community pharmacy shows its resiliency

Community pharmacy owners occupy a critical position in the pharmacy marketplace and, even more importantly, as health care providers in communities across the country. Most stakeholders in the profession understand the vital marketplace check and balance that independent businesses provide. If only two or three megachain drug stores existed, negotiations with payers would look very

CVS redoubles efforts to tackle opioid abuse

CVS redoubles efforts to tackle opioid abuse

WOONSOCKET, R.I — CVS Health has unveiled a sweeping plan that marshals its integrated pharmacy assets to help stem the rising tide of drug misuse and abuse, namely opioid painkillers. CVS said Thursday that its enterprisewide strategy to fight the opioid epidemic includes initiatives for safe drug disposal and utilization management of pain medications, as

Opioid epidemic’s impact on pharmacy sector

Opioid epidemic’s impact on pharmacy sector

The United States is battling what the Centers for Disease Control and Prevention (CDC) has labeled an epidemic of prescription drug abuse. According to CDC data, drug overdose deaths more than doubled between 2002 and 2015 (the latest year for which information is available). In 2015, drug overdose deaths exceeded 50,000 — which is more

CVS Health examines perceptions of opioid epidemic

CVS Health examines perceptions of opioid epidemic

WOONSOCKET, R.I. — Americans see prescription drug abuse as a growing problem that is increasingly impacting their lives, a new report from CVS Health has found. Released on Thursday, ahead of the Drug Enforcement Administration’s (DEA) National Prescription Drug Take Back Day, the report also finds that 75% of respondents believe the problem of prescription

Walgreens gets results in first year of Rx disposal program

Walgreens gets results in first year of Rx disposal program

DEERFIELD, Ill. — Walgreens has collected and safely disposed of 72 tons of medication since launching its drug disposal program 14 months ago. Walgreens said Wednesday that its safe medication disposal program is the first ongoing national effort of its kind by a retailer to combat the national drug abuse crisis and help fight the

Cardinal Health gives boost to Drug Take-Back Day

Cardinal Health gives boost to Drug Take-Back Day

DUBLIN, Ohio — As part of its effort to fight prescription drug abuse, the Cardinal Health Foundation is urging the public to participate in National Prescription Drug Take-Back Day on Saturday. The event, held April 29 from 10 a.m. to 2 p.m. and hosted by the Drug Enforcement Administration (DEA), aims to help prevent medication abuse

Kroger pharmacies integrate with Michigan PDMP

Kroger pharmacies integrate with Michigan PDMP

LOUISVILLE, Ky. — Kroger pharmacies in Michigan have integrated Michigan Automated Prescription System (MAPS) data and advanced analytics into their workflow to better track prescription drug abuse. Kroger’s integration into MAPS was facilitated by Appriss Health, a technology partner for Michigan’s prescription drug monitoring program (PDMP). Appriss Health said Tuesday that Kroger can now directly

Teva gets FDA’s OK for Vantrela ER

Teva gets FDA’s OK for Vantrela ER

JERUSALEM, Israel — Teva Pharmaceutical Industries Ltd. has received Food and Drug Administration approval for Vantrela ER, an opioid pain medication with Teva’s abuse deterrence technology. Vantrela ER (hydrocodone bitartrate extended-release tablets, CII) is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which other treatment options

McKesson to pay $150 million in DEA, DOJ settlement

McKesson to pay $150 million in DEA, DOJ settlement

SAN FRANCISCO — McKesson Corp. has agreed to pay $150 million in a settlement with the Drug Enforcement Administration (DEA) and Department of Justice (DOJ) involving its monitoring and reporting of suspicious controlled substance orders. McKesson said late Tuesday that under the administrative and civil settlements the DEA will suspend the company’s DEA registrations to

Four more states join NABP PMP InterConnect network

Four more states join NABP PMP InterConnect network

MOUNT PROSPECT, Ill. — Massachusetts, New Hampshire, New York and Texas have linked to the PMP InterConnect prescription monitoring program data-sharing system administered by the National Association of Boards of Pharmacy (NABP) and technology partner Appriss Health. With the addition of four states, NABP PMP InterConnect now has 37 states sharing PMP data over the network to

Cardinal Health settles civil portion of 2012 diversion case

Cardinal Health settles civil portion of 2012 diversion case

DUBLIN, Ohio — Cardinal Health Inc. has reached a nationwide settlement with the federal government that resolves the outstanding civil penalty portion of its 2012 administrative settlement with the Drug Enforcement Administration (DEA). Cardinal Health said it has agreed to pay $44 million to the Department of Justice (DOJ) under the settlement. The DOJ —

Walgreens deploys drug disposal kiosks in N.J.

Walgreens deploys drug disposal kiosks in N.J.

DEERFIELD, Ill. — Walgreens has launched its safe medication disposal kiosk program at 16 stores in New Jersey. The drug chain said drug take-back kiosks have been installed at stores in Carlstadt, East Brunswick, East Orange, Elizabeth, Elmwood Park, Hamilton, Jersey City, Millville, Neptune, Parsippany, Perth Amboy, Somerville, Toms River, Union and Waldwick. Installation of

QS/1 integrates with Appriss Health’s NARxCHECK

QS/1 integrates with Appriss Health’s NARxCHECK

SPARTANBURG, S.C. — QS/1 said it’s the first pharmacy management software provider to integrate partner with Appriss Health’s NARxCHECK into a pharmacy’s workflow. An analytics solution, NARxCHECK helps fight prescription drug abuse by giving pharmacies real-time access to data gathered by prescription drug monitoring programs (PDMPs), QS/1 noted, adding that the integration comes as more states

1 2 3
PP_1170x120_10-25-21